Drugs for Severe Cutaneous Adverse Reaction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 43)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
2 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 4 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
3 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
4 |
|
Calcineurin Inhibitors |
|
Phase 4 |
|
|
|
5 |
|
Cyclosporins |
|
Phase 4 |
|
|
|
6 |
|
Antifungal Agents |
|
Phase 4 |
|
|
|
7 |
|
Immunosuppressive Agents |
|
Phase 4 |
|
|
|
8 |
|
Ophthalmic Solutions |
|
Phase 4 |
|
|
|
9 |
|
Lenograstim |
Approved, Investigational |
Phase 2, Phase 3 |
|
135968-09-1 |
|
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
GRANOCYTE-13
GRANOCYTE-34
Granulocyte colony stimulating factor 3 (CHO cell derived)
|
Granulocyte colony-stimulating factor lenograstim
Lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
RG-CSF
|
|
10 |
|
Etanercept |
Approved, Investigational |
Phase 3 |
|
185243-69-0 |
|
Synonyms:
BENEPALI
CD120B
ENBREL
Enbrel Sureclick
Etanercept
etanercept-szzs
etanercept-ykro
FC
GP2015
GP-2015
GP2015C
HD203
L04AB01
|
LBEC0101
P75
P80 TNF-ALPHA RECEPTOR
Recombinant human TNF
RHU TNFR
rhu TNFR:Fc
rhu-TNFR:Fc
TNF-R2
TNFR-Immunoadhesin
TUMOR NECROSIS FACTOR RECEPTOR 2
TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B PRECURSOR
TUMOR NECROSIS FACTOR RECEPTOR TYPE II
|
|
11 |
|
Coal tar |
Approved |
Phase 3 |
|
8007-45-2 |
|
Synonyms:
|
12 |
|
Immunoglobulins, Intravenous |
|
Phase 3 |
|
|
|
13 |
|
Immunoglobulins |
|
Phase 3 |
|
|
|
14 |
|
Antibodies |
|
Phase 3 |
|
|
|
15 |
|
gamma-Globulins |
|
Phase 3 |
|
|
|
16 |
|
Rho(D) Immune Globulin |
|
Phase 3 |
|
|
|
17 |
|
Immunologic Factors |
|
Phase 2, Phase 3 |
|
|
|
18 |
|
Pharmaceutical Solutions |
|
Phase 2, Phase 3 |
|
|
|
19 |
|
Adjuvants, Immunologic |
|
Phase 2, Phase 3 |
|
|
|
20 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 3 |
|
|
|
21 |
|
Analgesics, Non-Narcotic |
|
Phase 3 |
|
|
|
22 |
|
Analgesics |
|
Phase 3 |
|
|
|
23 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 1, Phase 2 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
24 |
|
Riboflavin |
Approved, Investigational, Nutraceutical, Vet_approved |
Phase 1, Phase 2 |
|
83-88-5 |
493570 |
Synonyms:
(-)-Riboflavin
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol
6,7-Dimethyl-9-D-ribitylisoalloxazine
6,7-Dimethyl-9-ribitylisoalloxazine
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine
7,8-DIMETHYL-10-[(2S,3S,4R)-2,3,4,5-TETRAHYDROXYPENTYL]-2H,3H,4H,10H-BENZO[G]PTERIDINE-2,4-DIONE
7,8-Dimethyl-10-ribitylisoalloxazine
Beflavin
Beflavine
Benzo[g]pteridine riboflavin deriv.
Bisulase
e 101
e101
E-B2
Flavaxin
Flavin BB
Flaxain
FOOD Yellow 15
FREEDA
Hyre
INS NO. 101(I)
Lactobene
|
Lactoflavin
Lactoflavine
NCI-0033298
NSC-33298
Ribipca
Ribocrisina
Riboderm
Riboflavin
RIBOFLAVIN (VIT B2)
RIBOFLAVIN TETRABUTYRATE
Riboflavina
RIBOFLAVINE
Riboflavinum
Ribosyn
Ribotone
Ribovel
Russupteridine yellow III
San yellow b
Vitaflavine
Vitamin b 2
Vitamin b2
Vitamin Bi
Vitamin g
Vitasan b2
|
|
25 |
|
Folate |
|
Phase 1, Phase 2 |
|
|
|
26 |
|
Vitamins |
|
Phase 1, Phase 2 |
|
|
|
27 |
|
Vitamin B9 |
|
Phase 1, Phase 2 |
|
|
|
28 |
|
Trace Elements |
|
Phase 1, Phase 2 |
|
|
|
29 |
|
Photosensitizing Agents |
|
Phase 1, Phase 2 |
|
|
|
30 |
|
Vitamin B2 |
|
Phase 1, Phase 2 |
|
|
|
Synonyms:
|
31 |
|
Vitamin B Complex |
|
Phase 1, Phase 2 |
|
|
|
32 |
|
Micronutrients |
|
Phase 1, Phase 2 |
|
|
|
33 |
|
Benzocaine |
Approved, Investigational |
Phase 1 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
34 |
|
Tannic acid |
Approved |
Phase 1 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
35 |
|
Anesthetics |
|
Phase 1 |
|
|
|
36 |
|
Anesthetics, Local |
|
Phase 1 |
|
|
|
37 |
|
Allopurinol |
Approved |
|
|
315-30-0 |
2094 135401907 |
Synonyms:
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidin-4-one
1,5-Dihydro-4H-pyrazolo(3,4-D)pyrimidine-4-one
1H,2H,4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE
1H-Pyrazolo(3,4-D)pyrimidin-4-ol
4-HPP
4H-Pyrazolo(3,4-D)pyrimidin-4-one
4-Hydroxy-1H-pyrazolo(3,4-D)pyrimidine
4-Hydroxy-3,4-pyrazolopyrimidine
4-Hydroxypyrazolo(3,4-D)pyrimidine
4'-Hydroxypyrazolol(3,4-D)pyrimidine
4-Hydroxypyrazolopyrimidine
4-Hydroxypyrazolyl(3,4-D)pyrimidine
7HP
Adenock
Ailural
AL-100
Allohexal
Allohexan
Alloprin
Allopur
Allo-Puren
Allopurin
Allopurinol
Allopurinol alphapharm brand
Allopurinol amrad brand
Allopurinol aps brand
Allopurinol ashbourne brand
Allopurinol azupharma brand
Allopurinol basf brand
Allopurinol bicther brand
Allopurinol boots brand
Allopurinol clonmel brand
Allopurinol dorsch brand
Allopurinol douglas brand
Allopurinol gepepharm brand
Allopurinol hennig brand
Allopurinol hexal brand
Allopurinol horner brand
Allopurinol icn brand
Allopurinol jenapharm brand
Allopurinol merckle brand
Allopurinol merz brand
Allopurinol multipharma brand
Allopurinol nicholas brand
Allopurinol novopharm brand
Allopurinol pharmafarm brand
Allopurinol pinewood brand
Allopurinol protea brand
Allopurinol r.a.n. brand
Allopurinol rima brand
Allopurinol roche brand
Allopurinol rosen brand
Allopurinol rougier brand
Allopurinol Sodium
Allopurinol tad brand
Allopurinol thiemann brand
Allopurinol wellcome brand
Allopurinolum
ALLOPURINOLUM [INN-LATIN]
Allorin
Allozym
Allpargin
Allural
ALOPRIM
Aloprim®|BW-56-158|BW-56158|Zyloprim®
Alopurinol
ALOPURINOL [INN-SPANISH]
ALORAL
Alositol
Alphapharm brand OF allopurinol
Aluline
ALULINE 100
ALULINE 300
Amrad brand OF allopurinol
Anoprolin
Anzief
Apo-Allopurinol
APS brand OF allopurinol
Apulonga
Apurin
Apurol
Ashbourne brand OF allopurinol
Atisuril
Azupharma brand OF allopurinol
BASF brand OF allopurinol
Bicther brand OF allopurinol
Bleminol
Bloxanth
Boehringer mannheim brand OF allopurinol
Boots brand OF allopurinol
BW-56158
BW-56-158
Byk gulden brand OF allopurinol
Caplenal
Capurate
Cellidrin
|
Clonmel brand OF allopurinol
COSURIC
Dabrosin
Dabroson
Dorsch brand OF allopurinol
Douglas brand OF allopurinol
Dura Al
Embarin
Epidropal
Epuric
Fawns and mcallan brand OF allopurinol
Foligan
Geapur
Gepepharm brand OF allopurinol
Gichtex
Glaxo wellcome brand OF allopurinol
Gotax
Hamarin
HAMARIN 100
HAMARIN 300
Hennig brand OF allopurinol
Henning berlin brand OF allopurinol
Hexal brand OF allopurinol
Hexanuret
Horner brand OF allopurinol
HPP
ICN brand OF allopurinol
Jenapharm brand OF allopurinol
Jenapurinol
Ketanrift
Ketobun-A
LEDOPUR
Lopurin
Lysuron
Merckle brand OF allopurinol
Merz brand OF allopurinol
Milurit
Milurite
Miniplanor
Monarch
Multipharma brand OF allopurinol
Nektrohan
Nicholas brand OF allopurinol
Novopharm brand OF allopurinol
Novopurol
NSC-101655
NSC-1390
Pan quimica
Pharmafarm brand OF allopurinol
Pinewood brand OF allopurinol
Progout
Protea brand OF allopurinol
Pureduct
Purinol
Quimica, pan
R.A.N. brand OF allopurinol
Reig jofre brand OF allopurinol
Remid
Rhône poulenc rorer brand OF allopurinol
Rhône-poulenc rorer brand OF allopurinol
Riball
Rima brand OF allopurinol
Rimapurinol
Roche brand OF allopurinol
Rosen brand OF allopurinol
Roucol
Rougier brand OF allopurinol
Sigapurol
Suspendol
TAD brand OF allopurinol
Takanarumin
Thiemann brand OF allopurinol
Tipuric
Urbol
Uribenz
Uricemil
URICTO
Uridocid
Uriprim
Uripurinol
Uritas
Urobenyl
Urolit
Urosin
Urtias
Urtias 100
Wellcome brand OF allopurinol
Xanthomax
XANTHOMAX-100
XANTHOMAX-300
Xanturat
Xanturic
Zygout
Zyloprim
Zyloric
ZYLORIC-300
|
|
38 |
|
Lidocaine |
Approved, Vet_approved |
|
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
39 |
|
Isotretinoin |
Approved, Investigational, Nutraceutical |
|
|
302-79-4, 4759-48-2 |
5538 444795 5282379 |
Synonyms:
(13-cis)-Retinoate
(13-CIS)-RETINOIC ACID
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXENYL)NONA-2,4,6,8-TETRAENOIC ACID
(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate
(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENOIC ACID
(7E,9E,11E,13Z)-Retinoate
(7E,9E,11E,13Z)-RETINOIC ACID
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
13 cis Retinoic acid
13 CIS-RETINOIC ACID
13-cis-Retinoate
13-cis-Retinoate,isotretinoin
13-CIS-RETINOIC ACID
13-CIS-VITAMIN A ACID
13-RA
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoate
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoate (ecl)
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
Aberel
ABSORICA
ACCUTANE
Acid, all-trans-retinoic
Acid, beta-all-trans-retinoic
Acid, retinoic
Acid, trans-retinoic
Acid, vitamin a
Acide retinoique
ACIDE RETINOIQUE (FRENCH)
ACIDE RETINOIQUE (FRENCH) (DSL)
ACTICIN
AGN 100335
Airol
Aknefug
Aknoten
all trans Retinoic acid
all trans-Retinoic acid
all-(e)-Retinoate
all-(e)-Retinoic acid
all-trans-beta-Retinoate
all-trans-beta-Retinoic acid
all-trans-b-Retinoate
all-trans-b-Retinoic acid
all-trans-Retinoate
all-trans-Retinoic acid
ALL-TRANS-RETINOIC ACID (ATRA)
all-trans-retinoic acid (ATRA)|Altreno® (0.05% lotion)|Avita® (0.025% gel)|Renova® (0.02% cream)
all-trans-Tretinoin
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-Β-retinoate
all-trans-Β-retinoic acid
ALTRENO
AMNESTEEM
ATRA
Atra-IV
Atralin
Avita
beta all trans Retinoic acid
beta-all-trans-Retinoic acid
beta-Retinoate
beta-Retinoic acid
b-Retinoate
b-Retinoic acid
CIP-isotretinoin
CIS-RA
cis-Retinoate
|
CIS-RETINOIC ACID
CLARAVIS
Dermairol
Eudyna
ISOTRETINOIN
Isotretinoin zinc salt, 13 cis isomer
Isotretinoin zinc salt, 13-cis-isomer
Isotretinoina
Isotretinoína
Isotretinoine
Isotrétinoine
Isotretinoino
Isotretinoinum
ISOTREX
Lsotretinoin
MYORISAN
NEOVITAMIN A ACID
NSC-122758
PAT-001
Potassium salt, tretinoin
Renova
Retin a
Retin-a
Retin-a micro
RETIN-A-MICRO
Retinoate
Retinoic acid
RETINOIC ACID 13-CIS-FORM
Retionic acid
Retisol-a
Ro 1-5488
RO-43780
RO-4-3780
Roaccutan
ROACCUTANE
Roacutan
Salt, tretinoin potassium
Salt, tretinoin sodium
Salt, tretinoin zinc
Sodium salt, tretinoin
Solage
SOTRET
Stieva-a
Stieva-a Forte
Teriosal
trans Retinoic acid
trans-Retinoate
trans-Retinoic acid
Tretin m
Tretinoin
Tretinoin potassium salt
Tretinoin sodium salt
Tretinoin zinc salt
TRETINOIN、ATRA
Tretinoina
Trétinoïne
TRETINOINE (FRENCH)
TRETINOINE (FRENCH) (EINECS)
Tretinoinum
Tretin-X
Tri-Luma
Vesanoid
Vitamin a acid
Vitinoin
ZENATANE
Zinc salt, tretinoin
Β-retinoate
Β-retinoic acid
|
|
40 |
|
Anti-Bacterial Agents |
|
|
|
|
|
41 |
|
Proxymetacaine |
|
|
|
|
|
42 |
|
Lubricant Eye Drops |
|
|
|
|
|
43 |
|
Immunoglobulin A |
|
|
|
|
|
Interventional clinical trials:
(show all 32)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis |
Unknown status |
NCT02739295 |
Phase 4 |
recombinant granulocyte - colony stimulating factor;NaCl 0.9% |
2 |
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye |
Completed |
NCT01488396 |
Phase 4 |
0.05%cyclosporin eye drop |
3 |
NPB-01(Intravenous Immunoglobulin) Therapy for Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. |
Completed |
NCT01696500 |
Phase 3 |
Intravenous immunoglobulin |
4 |
Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface |
Completed |
NCT00346450 |
Phase 3 |
|
5 |
Evaluating the Therapeutic Efficacy of Filgrastim in Severe Bullous Drug Eruptions (Lyell and Stevens-Johnson Syndromes) |
Recruiting |
NCT04651439 |
Phase 2, Phase 3 |
Filgrastim;Placebo |
6 |
NATIENS: A Phase III Randomized Double-Blinded Placebo Controlled Study to Determine the Optimal Management and Mechanisms of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis |
Not yet recruiting |
NCT02987257 |
Phase 3 |
Harmonized supportive care;Cyclosporine 5 mg/kg bid days 0-14;Etanercept 50 mg sc day 0 and day 3 |
7 |
The Use of Riboflavin/Ultraviolet A Cross-linked Human Donor Corneas as Carriers for the Boston Keratoprosthesis |
Completed |
NCT01582880 |
Phase 1, Phase 2 |
Riboflavin |
8 |
Phase IIa Multicenter Clinical Trial to Determine the Feasibility and Safety of the Use of Adipose-derived Mesenchymal Stem Cells (ASC) in the Treatment of Patients With Cicatricial Conjunctivitis Associated With Lyell's Syndrome, Stevens-Johnson Syndrome and Pemphigoid of the Mucous Membranes With Ocular Involvement. |
Recruiting |
NCT05520086 |
Phase 1, Phase 2 |
Single Dose;Double Dose |
9 |
Mesenchymal Stromal Cells Treatment in Lyell Syndrome: A Pilot Phase 1-2 Open Trial |
Not yet recruiting |
NCT04711200 |
Phase 1, Phase 2 |
Adipose derived stromal cells intravenously injected |
10 |
Palifermin Treatment of Toxic Epidermal Necrolysis |
Terminated |
NCT02037347 |
Phase 1, Phase 2 |
Palifermin |
11 |
Infliximab Therapy to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis |
Withdrawn |
NCT01256489 |
Phase 1, Phase 2 |
Infliximab |
12 |
Topical Infliximab in Autoimmune Eyes With Keratoprosthesis |
Withdrawn |
NCT02126020 |
Phase 1, Phase 2 |
topical infliximab |
13 |
Pilot Study Comparing Remicade (Infliximab) vs. Standard Care in the Treatment of Toxic Epidermal Necrolysis |
Withdrawn |
NCT00372723 |
Phase 2 |
Remicaide (infliximab) |
14 |
A Randomized Placebo Controlled Split-body Double-blind Phase II Clinical Trial to Investigate the Safety and Efficacy of Clobetasol 0.05% Ointment for the Treatment of Toxic Epidermal Necrolysis (TEN) |
Withdrawn |
NCT02319616 |
Phase 1, Phase 2 |
Clobetasol 0.05% ointment;Placebo |
15 |
Platelet Rich-plasma in Management of Chronic Multiple Oral Ulcers |
Completed |
NCT03878771 |
Phase 1 |
Dermovate cream in Orabase |
16 |
Comparison of Corneal Epitheliotropic Factors in Autologous Serum Eye Drops Between Nonautoimmune Dry Eye and Stevens-Johnson Syndrome With Dry Eye |
Unknown status |
NCT01122303 |
|
|
17 |
A Prospective Study to Prove the Usefulness of HLA-B*5801 Screening Test for the Prevention of Allopurinol-induced Severe Cutaneous Adverse Reaction in Patient With Chronic Kidney Disease |
Unknown status |
NCT03046914 |
|
|
18 |
The Effects of Minor Salivary Gland Transplantation for Cicatrizing Conjunctivitis |
Unknown status |
NCT03839069 |
|
|
19 |
A Prospective Multicenter Cohort Study Assessing Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis |
Unknown status |
NCT03585946 |
|
Site specific standard of care comparison |
20 |
Evaluating the Effect of Isotretinoin in Regulatory T-cell Function in Adverse Cutaneous Drug Eruptions (ACDEs): A Pilot Study |
Unknown status |
NCT02795143 |
|
Isotretinoin |
21 |
The Multicenter Registry of Patients With Severe Cutaneous Adverse Reactions Among Tertiary Medical Institutes in Thailand |
Unknown status |
NCT02574988 |
|
|
22 |
Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs) |
Unknown status |
NCT03176342 |
|
|
23 |
Stevens-Johnson Syndrome Associated With Antimicrobial |
Completed |
NCT00844038 |
|
|
24 |
Salivary Gland and Labial Mucous Membrane Transplantation in the Treatment of Severe Symblepharon and Dry Eye in Patients With Stevens-Johnson Syndrome. |
Completed |
NCT01178242 |
|
|
25 |
Nutritional and Metabolic Characteristics of Critically Ill Patients Admitted for Severe Toxidermia |
Completed |
NCT05320653 |
|
|
26 |
A Prospective Open-label, Multicenter Clinical Investigation to Assess the Safety and Performance of ARGOS-IO System in Patients Undergoing Implantation of a Boston Keratoprosthesis (BKPro) |
Completed |
NCT02945176 |
|
|
27 |
An Evaluation of Tangible Boost Replenishing System for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Versus Host Disease |
Recruiting |
NCT04313725 |
|
|
28 |
Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis |
Recruiting |
NCT05145959 |
|
|
29 |
Adverse Cutaneous Drug Reactions Collection of Clinical Data and Biological Samples |
Recruiting |
NCT03659227 |
|
|
30 |
Increased Frequencies of Certain HLA Class II Alleles DRB1 and DQB1 in PV Patients Compared to Those in Healthy Donors Have Been Reported in Various Populations and Repeatedly Confirmed. Among the Russian Population, no Studies About the Association of PV and HLA Class II Genes Have Been Conducted. Thus, the Purpose of This Study Was to Investigate HLA Class II Alleles and Haplotypes in Russian Patients With Pemphigus Vulgaris. |
Recruiting |
NCT05284929 |
|
|
31 |
Association of Cytokines With the Development of Complications in Burn and Toxic Epidermal Necrolysis (TENS) Patients |
Recruiting |
NCT04252651 |
|
|
32 |
An Investigator-initiated Trial (IIT) on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation in Corneal Limbal Deficiency Patients |
Available |
NCT02149732 |
|
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Severe Cutaneous Adverse Reaction:
Embryonic/Adult Cultured Cells Related to Severe Cutaneous Adverse Reaction:
|